Salmonella-innovative targeting carrier: Loading with doxorubicin for cancer treatment.
Bacterial ghosts
Cell based delivery
Liver cancer
Salmonella
Targeted drug delivery system
Journal
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
ISSN: 1319-0164
Titre abrégé: Saudi Pharm J
Pays: Saudi Arabia
ID NLM: 9705695
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
02
06
2020
accepted:
21
08
2020
entrez:
2
11
2020
pubmed:
3
11
2020
medline:
3
11
2020
Statut:
ppublish
Résumé
Cell- based targeted delivery is recently gain attention as a promising platform for delivery of anticancer drug in selective and efficient manner. As a new biotechnology platform, bacterial ghosts (BGs) have novel biomedical application as targeted drug delivery system (TDDS). In the current work, Salmonellas' BGs was utilized for the first time as hepatocellular cancer (HCC)
Identifiants
pubmed: 33132719
doi: 10.1016/j.jsps.2020.08.016
pii: S1319-0164(20)30195-X
pmc: PMC7584810
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1253-1262Informations de copyright
© 2020 Published by Elsevier B.V. on behalf of King Saud University.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Toxicol Lett. 2008 Sep;181(1):1-6
pubmed: 18616992
Saudi Pharm J. 2018 Feb;26(2):232-237
pubmed: 30166921
Acta Pol Pharm. 2010 May-Jun;67(3):217-23
pubmed: 20524422
Biochemistry. 1979 Oct 2;18(20):4425-30
pubmed: 226126
Eur J Pharm Biopharm. 2020 Jan;146:133-142
pubmed: 31698041
Biochem Biophys Res Commun. 2011 Aug 5;411(3):569-73
pubmed: 21763280
Int J Pharm. 2011 Oct 10;418(1):13-7
pubmed: 21034800
J Neurochem. 1997 Aug;69(2):581-93
pubmed: 9231715
J Cancer. 2019 Aug 20;10(20):4765-4776
pubmed: 31598148
Biotechniques. 1997 Sep;23(3):525-31
pubmed: 9298227
Mol Cell Biochem. 2014 Apr;389(1-2):85-98
pubmed: 24399465
Crit Rev Ther Drug Carrier Syst. 2008;25(1):1-61
pubmed: 18540835
Microb Pathog. 1996 Nov;21(5):319-29
pubmed: 8938640
Invest Ophthalmol Vis Sci. 2013 Sep 24;54(9):6326-33
pubmed: 23920373
J Control Release. 2004 Jan 8;94(1):63-74
pubmed: 14684272
Gastroenterology. 1989 Oct;97(4):1055-6
pubmed: 2777029
J Drug Target. 2003 Apr;11(3):151-61
pubmed: 13129825
Toxicology. 2004 Sep 1;201(1-3):153-72
pubmed: 15297030
J Med Chem. 2009 Sep 10;52(17):5311-22
pubmed: 19725578
Int J Cancer. 2010 May 1;126(9):2025-35
pubmed: 19739078
Clin Cancer Res. 2009 Sep 15;15(18):5895-901
pubmed: 19737952
Int J Microbiol. 2016;2016:5678702
pubmed: 27190519
Cancer Res. 1997 Oct 15;57(20):4537-44
pubmed: 9377566
Cancer Lett. 2008 Apr 8;262(1):54-63
pubmed: 18164809
Angew Chem Int Ed Engl. 2004 Nov 26;43(46):6323-7
pubmed: 15558662
Cancer Sci. 2007 Jul;98(7):1107-12
pubmed: 17498202
Cytometry. 1996 Jun 1;24(2):131-9
pubmed: 8725662
Microbiol Mol Biol Rev. 2003 Dec;67(4):593-656
pubmed: 14665678
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Nat Biotechnol. 1999 Jan;17(1):37-41
pubmed: 9920266
J Control Release. 2001 Jun 15;73(2-3):255-67
pubmed: 11516503
Saudi Pharm J. 2014 Jul;22(3):273-9
pubmed: 25061413
Sci Rep. 2013 Dec 02;3:3394
pubmed: 24292152
Nat Protoc. 2006;1(3):1458-61
pubmed: 17406435
Med Sci Monit. 2018 Jan 24;24:473-478
pubmed: 29364864
Biotechnol Bioeng. 2006 Jul 5;94(4):710-21
pubmed: 16470601
Surgery. 2018 Mar;163(3):509-514
pubmed: 29229318
Curr Drug Deliv. 2020 Feb 10;:
pubmed: 32072911
J Pharm Sci. 1963 Dec;52:1145-9
pubmed: 14088963
AAPS PharmSciTech. 2019 Jan 7;20(2):48
pubmed: 30617674
Expert Opin Drug Deliv. 2006 Jan;3(1):11-22
pubmed: 16370937